Package Leaflet: Information for the User
Tadalafil Qualigen 10 mg film-coated tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Tadalafil Qualigen is indicated for the treatment of erectile dysfunction in adult men. This occurs when a man cannot obtain or maintain a firm erection suitable for satisfactory sexual activity. Tadalafil has been shown to significantly improve the ability to achieve a lasting erection of the penis suitable for sexual activity.
Tadalafil Qualigen contains the active ingredient tadalafil, which belongs to a group of medications called phosphodiesterase type 5 inhibitors. After sexual stimulation, Tadalafil Qualigen acts by helping to relax the blood vessels in the penis, allowing blood flow to the penis. The result is an improvement in erectile function. Tadalafil Qualigen will not help if you do not have erectile dysfunction.
It is essential to warn you that Tadalafil Qualigen is not effective if there is no sexual stimulation. Therefore, you and your partner should stimulate each other in the same way as you would if you were not taking a medication for erectile dysfunction.
Do not take Tadalafil Qualigen if:
Warnings and Precautions
Consult your doctor before starting to take Tadalafil Qualigen.
Be aware that sexual activity carries a possible risk in patients with heart problems, due to the additional effort it requires for the heart. If you have a heart problem, consult your doctor.
Before taking the tablets, inform your doctor if you have:
It is not known if Tadalafil Qualigen is effective in patients who have undergone:
If you experience a sudden decrease or loss of vision or your vision is distorted, blurred while taking Tadalafil Qualigen, stop taking Tadalafil Qualigen and contact your doctor immediately.
Tadalafil Qualigen is not intended for use in women.
Children and Adolescents
Tadalafil Qualigen should not be used in children or adolescents under 18 years of age.
Other Medications and Tadalafil Qualigen
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Do not take Tadalafil Qualigen if you are already using nitrates.
Some medications may be affected by Tadalafil Qualigen or may affect the proper functioning of Tadalafil Qualigen. Inform your doctor or pharmacist if you are using:
Taking Tadalafil Qualigen with Drinks and Alcohol
Information about the effect of alcohol can be found in section 3. Grapefruit juice may affect the proper functioning of Tadalafil Qualigen and should be taken with caution. Consult your doctor for more information.
Pregnancy, Breastfeeding, and Fertility
Fertility
In dogs treated with tadalafil, a decrease in sperm production by the testicles was observed. A reduction in sperm has been observed in some men. It is unlikely that these effects will produce a lack of fertility.
Driving and Using Machines
Some men who took tadalafil during clinical trials experienced dizziness. Carefully check how you react when taking the tablets before driving or using machines.
Tadalafil Qualigen Contains Lactose and Sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 23 mg of sodium (1 mmol) per tablet; this is, essentially "sodium-free".
Follow the administration instructions for this medication exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Tadalafil Qualigen tablets are for oral administration only in men. Swallow the tablet whole with a little water. The tablets can be taken with or without food.
The Recommended Initial Doseis one 10 mg tablet before sexual activity. If the effect of this dose is too weak, your doctor may increase the dose to 20 mg of tadalafil.
Not all recommended doses are possible using 10 mg tablets; tadalafil may also be available in 2.5, 5, and 20 mg tablets. Not all doses may be marketed.
When taking Tadalafil Qualigen, you can initiate sexual activity at least 30 minutes after taking it.
Tadalafil Qualigen may still be effective up to 36 hours after taking the tablet.
Do not take Tadalafil Qualigen more than once a day. Doses of 10 and 20 mg will be used before expected sexual activity and are not recommended for continuous daily use.
It is essential to warn you that Tadalafil Qualigen is not effective if there is no sexual stimulation. Therefore, you and your partner should stimulate each other in the same way as you would if you were not taking a medication for erectile dysfunction.
Consuming alcohol may affect your ability to have an erection and may temporarily lower your blood pressure. If you have taken or are planning to take Tadalafil Qualigen, avoid excessive alcohol consumption (blood alcohol level of 0.08% or higher), as it may increase the risk of dizziness when standing up.
The score line should not be used to split the tablet.
If You Take More Tadalafil Qualigen Than You Should
Consult your doctor. You may experience side effects described in section 4.
In case of overdose or accidental ingestion, consult the Toxicology Information Service, Phone: 91 562 04 20, indicating the medication and the amount taken. It is recommended to bring the packaging and the package leaflet of the medication to the healthcare professional.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, Tadalafil Qualigen can cause side effects, although not everyone will experience them. These effects are generally mild to moderate.
If you experience any of the following side effects, stop using the medication and seek medical help immediately:
Other side effects that have been reported:
Frequent(observed in 1 to 10 out of 100 patients)
flushing, nasal congestion, and indigestion.
Uncommon(observed in 1 to 10 out of 1,000 patients)
Rare(observed in 1 to 10 out of 10,000 patients)
Infarction and stroke have also been reported rarely in men taking Tadalafil Qualigen. Most of these men had pre-existing heart problems before taking this medication.
Rarely, cases of decreased or lost vision, partial, transient, or permanent in one or both eyes have been reported.
Some additional rare side effectshave been reported in men taking Tadalafil Qualigen that were not reported during clinical trials. These include:
In men over 75 years of age treated with Tadalafil Qualigen, the most frequently reported side effect was dizziness. In men over 65 years of age treated with Tadalafil Qualigen, the most frequently reported side effect was diarrhea.
Reporting Side Effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the box and blister pack after "EXP.". The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Film coating: poly(vinyl alcohol), macrogol (E-1521), titanium dioxide (E-171), talc, yellow iron oxide (E-172), red iron oxide (E-172).
Appearance of the Product and Package Contents
Tadalafil Qualigen 10 mg is an orange-pale, oblong, biconvex, and scored tablet.
Tadalafil Qualigen 10 mg is available in blister packs containing 4 tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona – Spain
Manufacturer
Pharmaceutical Works Polpharma SA
19 Pelplinska Street
83-200 Starogard Gdański
Poland
or
Pharmacare Premium Ltd,
HHF003, Hal Far Industrial Estate
Hal Far Birzebbugia, BBG3000,
Malta
or
Pharmaceutical Works Polpharma SA
2, Metalowca Street
39-460 Nowa Dęba
Poland
Date of the Last Revision of this Package Leaflet: October 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/